Interaction with Ppil3 leads to the cytoplasmic localization of Apoptin in tumor cells

De-Hua Huo1, Li-Na Yi, Jine Yang

  • 1The Key Laboratory of Gene Engineering of Ministry of Education, School of Life Sciences, Sun Yat-Sen (Zhongshan) University, 135th Xin-Gang-Xi Road, Guangzhou 510275, PR China.

Insights

Chicken anemia virus (CAV) protein Apoptin kills cancer cells by entering the nucleus. Human Peptidyl-prolyl isomerase-like 3 (Ppil3) binds Apoptin, retaining it in the cytoplasm and inhibiting cell death.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Apoptin, a protein from chicken anemia virus (CAV), selectively induces apoptosis in cancer cells.
  • Apoptin's cell-killing function is dependent on its nuclear localization, which occurs specifically in cancer cells.
  • The precise mechanisms regulating Apoptin's nucleocytoplasmic shuttling remain incompletely understood.

Purpose of the Study:

  • To identify proteins interacting with Apoptin and investigate their role in regulating its cellular localization.
  • To elucidate the function of Peptidyl-prolyl isomerase-like 3 (Ppil3) in Apoptin-mediated cell death.
  • To explore the potential of targeting the Apoptin-Ppil3 interaction for cancer therapy.

Main Methods:

  • Yeast two-hybrid screening to identify Apoptin-interacting proteins.
  • Co-immunoprecipitation and Western blotting to confirm direct binding between Apoptin and Ppil3.
  • Cellular localization studies using immunofluorescence microscopy in normal and cancer cell lines.
  • Manipulation of Ppil3 expression levels (overexpression and knockdown) to assess its impact on Apoptin localization.
  • Site-directed mutagenesis of Apoptin to investigate the role of specific residues in Ppil3 interaction.

Main Results:

  • Human Peptidyl-prolyl isomerase-like 3 (Ppil3) was identified as a direct binding partner of Apoptin.
  • Ppil3 binds Apoptin and retains it in the cytoplasm, even in cancer cells.
  • The nucleocytoplasmic distribution of Apoptin is directly correlated with the endogenous expression level of Ppil3.
  • Modulating Ppil3 levels exogenously alters Apoptin's localization.
  • An Apoptin mutant (P109A) located near putative nuclear signals significantly impaired Ppil3's inhibitory function.

Conclusions:

  • Ppil3 acts as a cytoplasmic anchor for Apoptin, inhibiting its nuclear translocation and subsequent cell death induction.
  • The interaction between Apoptin and Ppil3 represents a critical regulatory step in Apoptin's tumor-specific activity.
  • These findings offer new insights into Apoptin's localization mechanism and suggest Ppil3 as a potential therapeutic target in cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...